Drug Trial Radar · NCT05803421
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Last checked: Nov 20, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,749
Actual
Start
Apr 3, 2023
Primary completion
Mar 16, 2026
Study completion Mar 16, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Apr 7, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at increased cardiovascular risk. The study will last approximately 2 years may include up to 27 visits.
Conditions
- Type 2 Diabetes
- Obesity
- Overweight or Obesity
- Overweight
- Cardiovascular Diseases
- Chronic Kidney Disease
Interventions
OrforglipronDrug
Administered orally once daily
Insulin GlargineDrug
Administered SC once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Occurrence of Any Major Adverse Cardiovascular Event (MACE-4) [Myocardial Infarction (MI), Stroke, Hospitalization for Unstable Angina, or Cardiovascular (CV) Death]Time frame: Baseline to End of the Study (Approximate Maximum 104 Weeks)
Locations
358 sites in 16 countries. Site status is shown where the registry gives one.
Alliance for Multispecialty Research, LLC
Daphne, Alabama
Alliance for Multispecialty Research, LLC
Mobile, Alabama
Cahaba Research - Pelham
Pelham, Alabama
Syed Research Consultants Llc
Sheffield, Alabama
The Institute for Liver Health
Chandler, Arizona
Aventiv Research
Mesa, Arizona
Arizona Liver Health - Peoria
Peoria, Arizona
Elite Clinical Studies, LLC
Phoenix, Arizona
Absolute Clinical Research
Phoenix, Arizona
Clinical Research Institute of Arizona (CRI) - Sun City West
Sun City West, Arizona
Alliance for Multispecialty Research, LLC
Tempe, Arizona
Orange Grove Family Practice
Tucson, Arizona
KLR Business Group, Inc. dba Arkansas Clinical Research
Little Rock, Arkansas
Hope Clinical Research, Inc.
Canoga Park, California
Valley Clinical Trials, Inc.
Covina, California
Neighborhood Healthcare Institute of Health
Escondido, California
Valley Research
Fresno, California
Orange County Research Center
Lake Forest, California
Ark Clinical Research
Long Beach, California
Pacific Clinical Studies
Los Alamitos, California
Velocity Clinical Research, Los Angeles
Los Angeles, California
Infinity Clinical Research - Norco
Norco, California
Velocity Clinical Research, North Hollywood
North Hollywood, California
Valley Clinical Trials, Inc.
Northridge, California
Rancho Cucamonga Clinical Research
Rancho Cucamonga, California
LCGK Research
San Carlos, California
Norcal Endocrinology & Internal Medicine
San Ramon, California
Velocity Clinical Research, Coastal Heart Medical Group
Santa Ana, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Millennium Clinical Trials
Westlake Village, California
Rocky Mountain Regional VA Medical Center
Aurora, Colorado
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Legacy Clinical Trials
Colorado Springs, Colorado
CMR of Greater New Haven, LLC
Hamden, Connecticut
Orlando Heart & Vascular Institute
Altamonte Springs, Florida
JEM Research Institute
Atlantis, Florida
Excel Medical Clinical Trials
Boca Raton, Florida
Velocity Clinical Research, New Smyrna Beach
Edgewater, Florida
Alliance for Multispecialty Research, LLC
Fort Myers, Florida
Indago Research & Health Center, Inc
Hialeah, Florida
Showing 40 of 358 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.